Omeros (OMER) Net Margin Growth (1y) (2011 - 2022)

Omeros (OMER) Net Margin Growth (1y) (2011 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 3,245.00
Mar 31, 2022 2,297.00
Dec 31, 2021 48,743.00
Sep 30, 2021 21,920.00
Jun 30, 2021 58,280.00
Mar 31, 2021 19,537.00
Dec 31, 2020 -56,438.00
Sep 30, 2020 -9,215.00
Jun 30, 2020 -27,892.00
Mar 31, 2020 -1,162.00
Dec 31, 2019 -26,923.00
Sep 30, 2019 363,249.00
Jun 30, 2019 635,049.00
Mar 31, 2019 180,749.00
Dec 31, 2018 8,257.00
Sep 30, 2018 -314,584.00
Jun 30, 2018 -576,277.00
Mar 31, 2018 -134,277.00
Dec 31, 2017 132.00
Sep 30, 2017 -19,846.00